Many successful experiments have demonstrated that NMDA antagonists confer a neuroprotective effect against the progression of ischemic stroke52, 53, and GRIN2A is increased immediately after the onset of stroke symptoms7. The gene discussed is GRIN2A; the disease is Stroke.